| Financial Year |
March 31 2020 |
| Monetary Funds |
275,799,001.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
101,177,136.09 |
| Advances to Suppliers |
286,634.00 |
| Other Receivables |
4,032,212.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
524,719,463.73 |
| Other Current Assets |
138,288.33 |
| Total Current Assets |
906,152,735.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,727,624,365.41 |
| Long-term Equity Investment |
-- |
| Investment Properties |
54,063,392.65 |
| Fixed Assetes |
953,845.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
351,772,122.71 |
| R&D expenses |
-- |
| Goodwill |
143,875,009.28 |
| Long-Term Deferred and Prepaid Expenses |
29,517,765.78 |
| Deferred Income Tax Assets |
9,584,652.22 |
| Other Non-Current Assets |
1,456,300.00 |
| Sub-Total of Non-Current Assets |
2,318,847,453.88 |
| Total Assets |
3,225,000,189.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
51,400,000.00 |
| Accounts Payable |
1,047,262.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,633,604.43 |
| Taxes Payable |
12,337,635.35 |
| Interest Payable |
87,732,158.98 |
| Dividend Payable |
56,627.55 |
| Other payables |
158,446,689.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
257,065,133.84 |
| Other Current Liabilities |
192,000,000.00 |
| Sub-Total of Current Liabilities |
673,930,325.20 |
| Long-term Loans |
1,057,953,052.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,374,800.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
605,162,307.26 |
| Deferred Income Tax Liabilities |
964,655.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,679,454,815.70 |
| Total Liabilities |
2,353,385,140.90 |
| Paid-In Capital(Or Share Stock) |
661,890,508.00 |
| Capital Surplus |
389,875,873.53 |
| Surplus Reserve |
84,172,640.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-786,351,026.72 |
| Minority Stockholder's Interest |
521,313,014.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
350,302,033.94 |
| Owner's Equity（Stockholder's Equity） |
871,615,048.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,225,000,189.42 |
